Demant A/S (OTCMKTS:WILYY) Upgraded at Zacks Research

Demant A/S (OTCMKTS:WILYY) was upgraded by equities research analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a research report issued to clients and investors on Thursday, Zacks reports.

WILYY has been the subject of a number of other research reports. Sanford C. Bernstein downgraded Demant A/S from a “strong-buy” rating to a “hold” rating in a report on Friday, July 17th. UBS Group downgraded shares of Demant A/S from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 22nd. Finally, Morgan Stanley raised shares of Demant A/S from an “equal weight” rating to an “overweight” rating in a research report on Tuesday, June 23rd. Two analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Buy”.

Demant A/S Trading Down 3.8%

Demant A/S stock opened at $23.57 on Thursday. The business’s 50-day simple moving average is $22.64 and its two-hundred day simple moving average is $19.51. Demant A/S has a fifty-two week low of $13.45 and a fifty-two week high of $24.50.

About Demant A/S

Demant A/S is a Denmark-based hearing healthcare company that develops, manufactures and distributes products and services designed to help people with hearing loss and other communication needs. The company serves consumers and hearing care professionals through activities spanning hearing aids, diagnostic equipment, hearing care services and specialized communications technology.

Its portfolio includes hearing aids and related software, audiological diagnostic instruments, and technologies used by hearing care professionals to assess and manage hearing conditions.